[Comment] Global HIV targets: a roadmap to 2030 and beyond
This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has been substantial, particularly in the most affected eastern and southern Africa region, where new infections and AIDS-related deaths have each declined by almost 60% between 2010 and 2024.1 Globally, more than 77% of people living with HIV received antiretroviral therapy in 2024. In a subset of cou
# Editorial Summary
The global health community set an ambitious target a decade ago: eliminate AIDS as a public health threat by 2030 by cutting new HIV infections and AIDS-related deaths by 90% compared to 2010 levels. While this goal remains challenging, progress has been measurable and encouraging. Eastern and southern Africa—the regions most heavily impacted by HIV—have seen particularly significant improvements, with new infections and deaths each dropping by roughly 60% over the past 14 years. These gains demonstrate that coordinated international effort and investment in treatment can produce real results.
A major milestone has been the expansion of antiretroviral therapy (ART), the medications that allow people with HIV to live long, healthy lives and prevent transmission to others. As of 2024, more than three-quarters of people living with HIV globally are receiving this treatment. This widespread access to effective drugs represents a dramatic shift from earlier decades and has been crucial to reducing both deaths and new infections. However, the article suggests that some regions and populations still face barriers to accessing these life-saving treatments, indicating that work remains to close gaps in care.
The pathway to 2030 and beyond requires sustained commitment to increasing treatment access, improving prevention strategies, and ensuring that gains are maintained across all regions and communities. The data shows that when resources and political will align, meaningful progress is possible—but the global community must continue building on this foundation to reach the original targets and ultimately end the epidemic.
What consumers can do: If you're living with HIV or at risk, discuss prevention and treatment options with a healthcare provider. Support for accessible treatment programs and public health initiatives remains critical, and staying informed about HIV prevention methods—including PrEP (pre-exposure prophylaxis) for those at high risk—can help protect your health.
Read the full report at the original source
The LancetWas this finding useful?